Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical Neuroradiology
Published in: Clinical Neuroradiology 4/2016

01-12-2016 | Original Article

Chronic T2 Lesions in Multiple Sclerosis are Heterogeneous Regarding Phase MR Imaging

Authors: S. Siemonsen, MD, K.L. Young, MD, M. Bester, MD, Dr. rer. nat. J. Sedlacik, C. Heesen, MD, J. Fiehler, MD, J.-P. Stellmann, MD

Published in: Clinical Neuroradiology | Issue 4/2016

Login to get access

Abstract

Purpose

Phase imaging provides additional information on multiple sclerosis (MS) lesions and may in combination with mean diffusivity (MD) and magnetization transfer ratio (MTR) help differentiating heterogeneity of MS lesion pathology.

Methods

Magnetic resonance imaging (MRI) was performed in 23 MS patients including diffusion tensor imaging (DTI), magnetization transfer imaging (MTI), and SWI. Mean values (MTR, MD, and homodyne filtered phase) from 138 chronic MS lesions and normal appearing white matter (NAWM) were obtained and correlations examined. For explorative analysis, a divisive hierarchical clustering algorithm was applied.

Results

Phase characteristics were an independent characteristic of chronic T2 lesions, as MTR and MD were not correlated with phase values (R = − 0.23, R = − 0.18). Dependent on MTR, MD, and phase, cluster analysis led to five lesion groups. Of the two groups with phase values close to NAWM, one presented with highest MD and most severe MTR decrease (p  =  0.01), the other with slight MD increase and MTR decrease. Two lesion groups with highest phase values (p  =  0.01) displayed slightly increased MD and moderate decrease in MTR. Clinical data including EDSS, disease duration, and age did not differ significantly between groups.

Conclusions

Increased phase is predominantly detectable in lesions with clear MTR decrease but only moderate MD increase. Phase images seem to represent an independent parameter for MS lesion characterization and may provide additional information on MS lesion heterogeneity.
Literature
1.
Daumer M, Neuhaus A, Morrissey S, Hintzen R, Ebers GC. MRI as an outcome in multiple sclerosis clinical trials. Neurology. 2009;72(8):705–11. doi:10.1212/01.wnl.0000336916.38629.43.CrossRefPubMed
2.
Zivadinov R. Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? Neurology. 2007;68(22 Suppl 3):S72–82. doi:10.1212/01.wnl.0000275236.51129.d2.CrossRefPubMed
3.
Committee for Medicinal Products for Human Use (CHMP) Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis. European Medicines Agency. 2012; EMA/CHMP/771815/2011, Rev2.
4.
Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, Khan A, Ayaz M, Kirsch W, Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005;23(1):1–25. doi:10.1016/j.mri.2004.10.001.CrossRefPubMed
5.
Bagnato F, Hametner S, Yao B, van Gelderen P, Merkle H, Cantor FK, Lassmann H, Duyn JH. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain. 2011;134(Pt 12):3602–15. doi:10.1093/brain/awr278.CrossRefPubMed
6.
Yao B, Li TQ, Gelderen P, Shmueli K, de Zwart JA, Duyn JH. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage. 2009;44(4):1259–66. doi:10.1016/j.neuroimage.2008.10.029.CrossRefPubMed
7.
He X, Yablonskiy DA. Biophysical mechanisms of phase contrast in gradient echo MRI. Proc Natl Acad Sci U S A. 2009;106(32):13558–63. doi:10.1073/pnas.0904899106.CrossRefPubMedPubMedCentral
8.
Li TQ, Yao B, van Gelderen P, Merkle H, Dodd S, Talagala L, Koretsky AP, Duyn J. Characterization of T(2)* heterogeneity in human brain white matter. Magn Reson Med. 2009;62(6):1652–7. doi:10.1002/mrm.22156.CrossRefPubMedPubMedCentral
9.
Haacke EM, Makki M, Ge Y, Maheshwari M, Sehgal V, Hu J, Selvan M, Wu Z, Latif Z, Xuan Y, Khan O, Garbern J, Grossman RI. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging. 2009;29(3):537–44. doi:10.1002/jmri.21676.CrossRefPubMedPubMedCentral
10.
Eissa A, Lebel RM, Korzan JR, Zavodni AE, Warren KG, Catz I, Emery DJ, Wilman AH. Detecting lesions in multiple sclerosis at 4.7 T using phase susceptibility-weighting and T2-weighting. J Magn Reson Imaging. 2009;30(4):737–42. doi:10.1002/jmri.21926.CrossRefPubMed
11.
Walsh AJ, Blevins G, Lebel RM, Seres P, Emery DJ, Wilman AH. Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. Radiology. 2014;270(1):186–96. doi:10.1148/radiol.13130474.CrossRefPubMed
12.
Walsh AJ, Lebel RM, Eissa A, Blevins G, Catz I, Lu JQ, Resch L, Johnson ES, Emery DJ, Warren KG, Wilman AH. Multiple sclerosis: validation of MR imaging for quantification and detection of iron. Radiology. 2013;267(2):531–42. doi:10.1148/radiol.12120863.CrossRefPubMed
13.
Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B. 1996;111(3):209–19.CrossRefPubMed
14.
Fox RJ. Picturing multiple sclerosis: conventional and diffusion tensor imaging. Semin Neurol. 2008;28(4):453–66. doi:10.1055/s-0028-1083689.CrossRefPubMed
15.
Seewann A, Vrenken H, van der Valk P, Blezer EL, Knol DL, Castelijns JA, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol. 2009;66(5):601–9. doi:10.1001/archneurol.2009.57.CrossRefPubMed
16.
Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol. 2004;56(3):407–15. doi:10.1002/ana.20202.CrossRefPubMed
17.
Filippi M, Agosta F. Magnetization transfer MRI in multiple sclerosis. J Neuroimaging. 2007;17(Suppl 1):22S–6S. doi:10.1111/j.1552-6569.2007.00132.x.CrossRefPubMed
18.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302. doi:10.1002/ana.22366.CrossRefPubMedPubMedCentral
19.
van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, Lycklama à Nijeholt GJ, van der Valk P, Polman CH, Thompson AJ, Barkhof F. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 1999;46(5):747–54.CrossRefPubMed
20.
Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal. 2001;5(2):143–56.CrossRefPubMed
21.
Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, Nelson SJ, Pelletier D. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol. 2008;64(6):707–13. doi:10.1002/ana.21582.CrossRefPubMed
22.
Yao B, Bagnato F, Matsuura E, Merkle H, van Gelderen P, Cantor FK, Duyn JH. Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging. Radiology. 2012;262(1):206–15. doi:10.1148/radiol.11110601.CrossRefPubMedPubMedCentral
23.
Droogan AG, Clark CA, Werring DJ, Barker GJ, McDonald WI, Miller DH. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. Magn Reson Imaging. 1999;17(5):653–61. doi:S0730-725X(99)00011-9.CrossRefPubMed
24.
Rovaris M, Gambini A, Gallo A, Falini A, Ghezzi A, Benedetti B, Sormani MP, Martinelli V, Comi G, Filippi M. Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution. Neurology. 2005;65(10):1626–30. doi:10.1212/01.wnl.0000184493.06254.a6.CrossRefPubMed
25.
Basser PJ. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed. 1995;8(7–8):333–44.CrossRefPubMed
26.
De Groot CJ, Bergers E, Kamphorst W, Ravid R, Polman CH, Barkhof F, van der Valk P. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain. 2001;124(Pt 8):1635–45.CrossRefPubMed
27.
Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Bruck W. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol. 2001;49(6):793–6.CrossRefPubMed
28.
Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S, Geurts J, Polman CH, van der Valk P. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol. 2003;60(8):1073–81. doi:10.1001/archneur.60.8.1073.CrossRefPubMed
29.
Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol. 1997;42(5):783–93. doi:10.1002/ana.410420515.CrossRefPubMed
30.
Sahraian MA, Radue EW, Haller S, Kappos L. Black holes in multiple sclerosis: definition, evolution, and clinical correlations. Acta Neurol Scand. 2010;122(1):1–8. doi:10.1111/j.1600-0404.2009.01221.x.CrossRefPubMed
31.
van Walderveen MA, Kamphorst W, Scheltens P, van Waesberghe JH, Ravid R, Valk J, Polman CH, Barkhof F. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 1998;50(5):1282–8.CrossRefPubMed
32.
Barkhof F, Karas GB, van Walderveen MA. T1 hypointensities and axonal loss. Neuroimaging Clin N Am. 2000;10(4):739–52.PubMed
33.
Lassmann H. The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin N Am. 2008;18(4):563–76. doi:10.1016/j.nic.2008.06.005.CrossRefPubMed
34.
Rovaris M, Gass A, Bammer R, Hickman SJ, Ciccarelli O, Miller DH, Filippi M. Diffusion MRI in multiple sclerosis. Neurology. 2005;65(10):1526–32. doi:10.1212/01.wnl.0000184471.83948.e0.CrossRefPubMed
35.
Yablonskiy DA, Luo J, Sukstanskii AL, Iyer A, Cross AH. Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis. Proc Natl Acad Sci U S A. 2012;109(35):14212–7. doi:10.1073/pnas.1206037109.CrossRefPubMedPubMedCentral
36.
Wiggermann V, Hernandez Torres E, Vavasour IM, Moore GR, Laule C, MacKay AL, Li DK, Traboulsee A, Rauscher A. Magnetic resonance frequency shifts during acute MS lesion formation. Neurology. 2013;81(3):211–8. doi:10.1212/WNL.0b013e31829bfd63.CrossRefPubMedPubMedCentral
Metadata
Title
Chronic T2 Lesions in Multiple Sclerosis are Heterogeneous Regarding Phase MR Imaging
Authors
S. Siemonsen, MD
K.L. Young, MD
M. Bester, MD
Dr. rer. nat. J. Sedlacik
C. Heesen, MD
J. Fiehler, MD
J.-P. Stellmann, MD
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Clinical Neuroradiology / Issue 4/2016
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-015-0389-8

Other articles of this Issue 4/2016

Clinical Neuroradiology 4/2016 Go to the issue

Original Article

The Infundibular Recess Passes through the Entire Pituitary Stalk

Correspondence

Correlating Hemodynamic Changes and Occlusion Time after Flow Diverter Treatment of Bilateral Large Internal Carotid Artery Aneurysms

Correspondence

Anatomic and Quantitative Temporal Bone CT for Preoperative Assessment of Branchio-Oto-Renal Syndrome

Editorial

Intracranial Stenting in Germany

Original Article

Between-Scanner and Between-Visit Variation in Normal White Matter Apparent Diffusion Coefficient Values in the Setting of a Multi-Center Clinical Trial

Original Article

Preoperative Embolization to Improve the Surgical Management and Outcome of Juvenile Nasopharyngeal Angiofibroma (JNA) in a Single Center: 10-Year Experience